Vitranu is a startup based in the United States, most recent round Seed.
Vitranu is a company headquartered in the United States. Its most recent tracked round is Seed.
Vitranu develops TERC™, a tunable extended-release capsule technology designed to sustain delivery of therapeutics for eye diseases, aiming to reduce the frequency of injections required for treatment of wet Age-Related Macular Degeneration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.